News
We are pleased to announce our expanded office hours offering evening appointments on Tuesdays in addition to same day/next day appointments during 12-1pm. Please call us now for an appointment at (302) 571-8958 or by using our online appointment form.
USA Delaware is pleased to announce that Fran Schanne, MD, FACS has been voted a "2013 Top Doc" by the readers of Delaware Today. We are proud to be the first urologists in Delaware to offer robotic surgery for prostate cancer, bladder cancer and kidney cancer using the da Vinci Surgical system. Top Doctors Comcast NewsMakers |
Ureteroscopy
A common surgical treatment of kidney stones is ureteroscopy. This involves going under anesthesia so that we can place a cystoscope in the bladder and then through the cystoscope we can place an even smaller scope, an ureteroscope, into the ureter. With the ureteroscope we can break up and remove stones in the ureter and kidney. After this procedure, you will need a plastic tube left in the ureter. This tube is called a ureteral stent and protects the ureter and kidney while the ureter is healing. Generally, this stent remains in place for seven or more days.
There is a lot of uncertainty with renal stone management. Many factors impact the outcome of any management course you elect to take. You could choose to do nothing. Stones up to 10 mm (1cm) can pass on their own. Roughly, the chance of a stone passing spontaneously is inversely related to the stone size in millimeters. A 1mm stone passes 90% of the time, a 5 mm stone 50% of the time, a 9 mm stone 10% of the time and so on. The chance of passing stone fragments (including fragments remaining after a successful stone therapy) also depends on the kidney and ureter anatomy that you were born with. A dilated ureter after stent removal (a ureteral stent can cause the ureter to widen or dilate over time) is usually more able to accommodate larger stone fragments. Any of the common stone therapies, Extracorporeal Shock Wave Lithotripsy (ESWL), ureteroscopy (URS), and Percutaneous Nephrolithotomy (PCNL) will leave behind some stone fragments that the patient must pass post-operatively. It is not uncommon to have to return to the operating room a second or third time to remove all the stone fragments. However, in most cases, stones can be successfully eradicated with one trip to the operating room. Of these three stone therapies (ESWL, URS, and PCNL) PCNL is the most aggressive and has the greatest chance of making you stone-free with one trip to the operating room. PCNL requires having a tube placed into the kidney through the back by a radiologist. Then at a later time we can place instruments through this tube and into the kidney to remove the stones. Sometimes this procedure is done the same day that the tube is placed. PCNL is most appropriate for very large, complex stones, in patients who already have a nephrostomy tube in the ureter, or in patients who have special anatomic problems in their urinary tract. ESWL is least likely to make you stone-free in one trip to the operating room but usually does not require any stents or tubes. ESWL is most appropriate for small stones in the kidney or upper ureter. ESWL involves a special machine that can direct ultrasonic energy toward the stone without placing any instruments inside the body. The key to successful ESWL is being able to accurately focus the shock wave energy at the stone. For this reason, stones less than 5mm size, stones that are not visible on plain x-rays, and stones hidden by the pelvic bones (lower ureteral stones) are difficult to treat with ESWL. Some large stones treated with ESWL will require stent placement. In some cases cystoscopy and placement of a ureteral stent can be used as treatment of a kidney stone. The stent dilates the ureter and makes the ureter wider (temporarily) and therefore, more likely to allow stone passage. Sometimes the stone or stone fragments are passed when the stent is removed and sometimes stone passage occurs a short time after stent removal. Commonly, stent placement is used during an acute stone episode to relieve obstruction of the ureter. In these cases URS, ESWL, or PCNL may be scheduled electively after stent placement. Terms:
For ureteroscopy, stone extraction, and stent placement you may be given Ditropan (oxybutynin) 5mg tablets. Initially (the first day or two after the procedure) you should take 1 tablet every 6-8 hours. 1-2 days after the procedure you can simply take the tablets when you feel that you need it (when you are having bladder spasms). Alternatively, you may be given a once-a-day anticholinergic such as Detrol. In time many patients stop having bladder spasms and can stop taking this medication. Ureteroscopy Post-Op Instructions
Problems you should report to us:
You will also have some burning with urination. This is normal after stone therapy and is also expected while the stent is in place. This burning should be mild or moderate and should improve over time. Severe burning, especially when it is not improving, can be a sign of infection. Follow-Up |